Literature DB >> 10748015

Structure and promoter analysis of the human unc-33-like phosphoprotein gene. E-box required for maximal expression in neuroblastoma and myoblasts.

T Matsuo1, J K Stauffer, R L Walker, P Meltzer, C J Thiele.   

Abstract

The human unc-33-like phosphoprotein (hUlip/CRMP-4) is a member of a family of developmentally regulated genes that are highly expressed in the nervous system. Mutations in the C. elegans unc-33 gene lead to worms with abnormal movements. The hUlip gene encodes a 570-amino acid protein with 98% homology to its murine (Ulip) (Byk, T., Dobransky, T., Cifuentes-Diaz, C., and Sobel, A. (1996) J. Neurosci. 16, 688-701) and rat (CRMP-4) (Wang, L. H., and Strittmatter, S. M. (1996) J. Neurosci. 16, 6197-6207) counterparts (Gaetano, C., Matsuo, T., and Thiele, C. J. (1997) J. Biol. Chem. 272, 12195-12201). The hUlip gene was isolated from a human genomic library. It contains 15 exons, including an exon defined by an anaplastic oligodendroglioma expressed sequence tag, and spans at least 61.7 kilobases. hUlip lacks sequences corresponding to the first six exons found in unc-33. unc-33 exons correspond to homologous hUlip exons as follows: VII to 1 and 2, VIII to 3-9, IX to 10-12, and X to 13 and 14. Using the hUlip clone 1 phage, fluorescence in situ hybridization analysis indicates that the hybridization signal localizes to human chromosome 5q32. Deletion analysis of 5'-flanking sequences delineated the sequences sufficient to express a reporter gene in both neuroblastoma cells and myoblasts. A consensus MyoD/myogenin binding site is located in a region of the downstream promoter that is nearly identical to its mouse homologue. Mutagenesis shows that this conserved MyoD/myogenin site is necessary for full promoter activity in both myoblasts and neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748015     DOI: 10.1074/jbc.M001312200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone.

Authors:  Christopher C Quinn; Esteban Chen; Tashi G Kinjo; Gail Kelly; Alexander W Bell; Robert C Elliott; Peter S McPherson; Susan Hockfield
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α.

Authors:  Katsuya Nakamura; Fei Tan; Zhijie Li; Carol J Thiele
Journal:  Mol Cell Neurosci       Date:  2010-12-09       Impact factor: 4.314

3.  Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.

Authors:  Hisaharu Oya; Mitsuro Kanda; Hiroyuki Sugimoto; Dai Shimizu; Hideki Takami; Soki Hibino; Ryoji Hashimoto; Yukiyasu Okamura; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Masahiko Koike; Shuji Nomoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2014-08-31       Impact factor: 7.527

4.  Expression of collapsin response mediator protein 1 in placenta of normal gestation and link to early-onset preeclampsia.

Authors:  Chong Qiao; Chunhui Wang; Feng Jin; Dongying Zheng; Caixia Liu
Journal:  Reprod Sci       Date:  2014-09-06       Impact factor: 3.060

Review 5.  Collapsin response mediator protein-1: a novel invasion-suppressor gene.

Authors:  Jin-Yuan Shih; Yuan-Chii G Lee; Shuenn-Chen Yang; Tse-Ming Hong; Chi-Ying F Huang; Pan-Chyr Yang
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.

Authors:  Mitsuro Kanda; Shuji Nomoto; Hisaharu Oya; Dai Shimizu; Hideki Takami; Soki Hibino; Ryoji Hashimoto; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  J Exp Clin Cancer Res       Date:  2014-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.